This article evaluates the effectiveness of neoadjuvant immunotherapy combined with chemotherapy (IC+Chemo) in treating non-small cell lung cancer (NSCLC). This large-scale study involved 1,092 patients from 11 medical centers and compared outcomes between those who received IC+Chemo and those who received chemotherapy alone.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
May 29, 2024
This study evaluated the surgical and oncological results of RATS thymectomy to demonstrate the approach as technically safe with acceptable outcomes. Of 669 patients, complete thymectomy was performed in 98 percent of cases and in 8.5 percent of those cases, resection of surrounding structures was undertaken.
May 23, 2024
Sublobar resection for early-stage non-small cell lung cancer has recently been compared with lobectomy in three randomized trials. This expert review summarizes and compares these three landmark trials and describes how these new data inform best practice.
May 2, 2024
Of 57,531 patients who underwent lung cancer resection identified from The Society of Thoracic Surgeons General Thoracic Surgery Database, 758 (1.3 percent) were diagnosed with pulmonary embolism, which was most likely in patients with locally advanced disease who underwent bilobectomy (6 percent versus 4 percent, P < .001) or pneumonectomy (8 per
April 18, 2024
This study reviews 44 patients with stage IB (larger than 4 cm) to IIIA non-small cell lung cancer who were treated on sequential platform arms of the NEOSTAR trial. Twenty-two patients were treated with nivolumab and chemotherapy and 22 patients were treated with ipilimumab, nivolumab, and chemotherapy.
April 10, 2024
The authors of this paper explored early postoperative outcomes in all patients (n= 833) undergoing uniportal segmentectomy and lobectomy in their unit between 2017 and 2022. During this study period, the utilization of uniportal access operations increased.
March 27, 2024
This study aimed to evaluate the percentage of solitary fibrous pleural tumors presenting unfavorable clinical behavior to predict negative long-term outcomes.
February 21, 2024
This study surveyed 123 thoracic surgeons and posed several questions asking which surgical resection they would prefer if they themselves were diagnosed with several variations of lung cancer size and location.
Rapid Discharge After Anatomic Lung Resection: Is Ambulatory Surgery for Early Lung Cancer Possible?
February 14, 2024
In this single-center series of 430 patients with stage I or II non-small cell lung cancer who underwent minimally invasive lobectomy (n = 200) or segmentectomy (n = 230), 162 (37 percent) were discharged less than 18 hours postoperatively without a chest tube, and 37 patients were discharged the day of surgery.
January 11, 2024
Spread through air spaces (STAS) is a recently identified marker that predicts worse outcomes in patients with lung cancer and is postulated to be one of the reasons why some patients with early-stage lung adenocarcinoma have uncharacteristically high locoregional recurrence rates.